Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Fennec Pharmaceuticals Ord Shs T.FRX

Alternate Symbol(s):  FENC

Healthcare Biotechnology
Fennec Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company, which is focused on its product candidate PEDMARK. The Company sells its product through a field force, including regional pediatric oncology specialists and medical science liaisons who are helping to educate the medical communities and patients about cisplatin induced ototoxicity and its programs supporting patient... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:FRX)

Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update

GlobeNewswire March 21, 2024

Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024

GlobeNewswire March 19, 2024

Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand

GlobeNewswire March 17, 2024

Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results

GlobeNewswire February 29, 2024

FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin

GlobeNewswire February 1, 2024

Fennec Announces Incremental $5 Million Investment from Petrichor

GlobeNewswire December 5, 2023

Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire November 9, 2023

Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update

GlobeNewswire November 6, 2023

Fennec Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 6, 2023

GlobeNewswire October 30, 2023
View More News ››

Opinion & Analysis (TSX:FRX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSX:FRX)

Fennec Pharmaceuticals Reports Full Year and Fourth Quarter

~ Achieved PEDMARK® Full-Year 2023 Net Product Sales of $21.3 Million, Including $9.7 Million in Net Product Sales in the...
Betteryear2 - March 21, 2024

Norgine exclusive agreement

for Europe.  Should be a good day for Fennec !!! Still waiting on that buyout
willyk3 - March 17, 2024

RE:Pedmark approved

Pedmark commercially available as of today!!! Great news for everyone involved..investors and patients alike.
willyk3 - October 17, 2022

Pedmark approved

by the US FDA.    Finally!!!! Now ....about that takeout??
willyk3 - September 21, 2022

Fennec Pharmaceuticals Up to $45 M Investment From Petrichor

~ Under the Terms of the Investment Agreement, $5 Million to be Funded on initial closing and $20 Million to be Funded Upon Potential...
Betteryear2 - August 1, 2022

RE:RE:IS THIRD TIME THE CHARM FOR FENNEC PHARMACEUTICALS?

The obvious solution at this stage is to just sell the darn company (at a discount) to a real pharmaceautical company who  has the...
willyk3 - December 13, 2021
View more Bullboard ››

Fokus Mining Corp

Fokus Mining Corp

Fokus Mining Corporation is a Canada-based mineral resource company. The Company is engaged in acquiring, exploring and ...
View More »